NASDAQ:JAGX

Jaguar Health - JAGX Stock Forecast, Price & News

$4.19

-0.30 (-6.68%)

(As of 02/8/2023 12:00 AM ET)

Add

Compare

Today's Range: $4.16
▼
$4.52
50-Day Range: $0.08
▼
$5.43
52-Week Range: $4.16
▼
$61.49

Volume: 303,075 shs
Average Volume: 410,867 shs
Market Capitalization: $8.09 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

About Jaguar Health (NASDAQ:JAGX) Stock

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The firm focuses on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Receive JAGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.

JAGX Stock News Headlines

February 1, 2023 | finance.yahoo.com

Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development

February 1, 2023 | finance.yahoo.com

Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling

February 9, 2023 | Paradigm Press (Ad)

Biden Likely HATES This Video

Biden just signed an order that wages WAR on every American Patriot. It’s an order that could make it 100% legal for the government to track your every move… That’s why Biden would HATE this video. Inside, it explains – in detail – how to beat back the government…

February 1, 2023 | americanbankingnews.com

StockNews.com Begins Coverage on Jaguar Health (NASDAQ:JAGX)

January 30, 2023 | finance.yahoo.com

Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise

January 26, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe

January 26, 2023 | finance.yahoo.com

Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe

January 25, 2023 | finance.yahoo.com

Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer

February 9, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,476%

Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%...Boeing soared 4,238%...L3Harris shot up 1,628%...

January 23, 2023 | investorplace.com

Is Jaguar Health (JAGX) Stock Really Up 6,800%?

January 23, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences

January 20, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st

January 20, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders

January 20, 2023 | finance.yahoo.com

Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st

January 20, 2023 | finance.yahoo.com

Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders

January 14, 2023 | benzinga.com

REMINDER: Jaguar Health to Hold Investor Webcast...

January 11, 2023 | finance.yahoo.com

REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar’s Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Derived from Psychoactive Plants

January 10, 2023 | msn.com

6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements

January 10, 2023 | markets.businessinsider.com

Jaguar Health's JV To Develop Botanical Pharmaceutical Drug Candidates For Mental Health Illnesses

January 10, 2023 | finance.yahoo.com

Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health Illnesses

January 10, 2023 | finance.yahoo.com

Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar's Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Derived from Psychoactive Plants

December 19, 2022 | finance.yahoo.com

Jaguar Health Provides Updates on Presentation at the World Congress of Gastroenterology About Crofelemer for Pediatric Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDD) by Third-Party Investigator

December 5, 2022 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Subsidiary Napo Pharmaceuticals Sponsors Episode of The Gayly Dose Focused on HIV-related Diarrhea

December 5, 2022 | finance.yahoo.com

Jaguar Health Subsidiary Napo Pharmaceuticals Sponsors Episode of The Gayly Dose Focused on HIV-related Diarrhea

November 21, 2022 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Hosts Symposium on the Management of Cancer Therapy-related Diarrhea

November 21, 2022 | finance.yahoo.com

Jaguar Health Hosts Symposium on the Management of Cancer Therapy-related Diarrhea

November 14, 2022 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive JAGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.

JAGX Company Calendar

Last Earnings: 11/14/2022
Today: 2/08/2023
Next Earnings (Estimated): 3/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:JAGX
CUSIP: N/A
CIK: 1585608
Web: www.jaguaranimalhealth.com
Phone: (415) 371-8300
Fax: N/A
Employees: 52
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($71.4286)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-52,600,000.00
Net Margins: -502.84%
Pretax Margin: -505.58%
Return on Equity: -823.56%
Return on Assets: -104.53%

Debt

Debt-to-Equity Ratio: 5.56
Current Ratio: 0.94
Quick Ratio: 0.69

Sales & Book Value

Annual Sales: $4.34 million
Price / Sales: 1.86
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $17.66 per share
Price / Book: 0.24

Miscellaneous

Outstanding Shares: 1,930,000
Free Float: 1,913,000
Market Cap: $8.09 million
Optionable: Not Optionable
Beta: 1.65

Key Executives

Lisa A. Conte
President, Chief Executive Officer & Director

Carol R. Lizak
Chief Financial Officer

Pravin Ramsewak Chaturvedi
Chief Scientific Officer

Jonathan S. Wolin
Chief of Staff & Chief Compliance Officer

Karen J. Brunke
Executive VP-Corporate & Business Development

Key Competitors

View All Competitors

Insiders & Institutions

View All Institutional Transactions

JAGX Stock - Frequently Asked Questions

How have JAGX shares performed in 2023?: Jaguar Health's stock was trading at $0.0869 at the start of the year. Since then, JAGX shares have increased by 4,779.2% and is now trading at $4.24.
View the best growth stocks for 2023 here.
When is Jaguar Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, March 10th 2023.
View our JAGX earnings forecast.
How were Jaguar Health's earnings last quarter?: Jaguar Health, Inc. (NASDAQ:JAGX) announced its quarterly earnings results on Monday, November, 14th. The biotechnology company reported ($0.12) EPS for the quarter. The biotechnology company had revenue of $3.15 million for the quarter. Jaguar Health had a negative trailing twelve-month return on equity of 823.56% and a negative net margin of 502.84%.
When did Jaguar Health's stock split?: Jaguar Health shares reverse split on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 8th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.
What other stocks do shareholders of Jaguar Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT).

When did Jaguar Health IPO?: (JAGX) raised $22 million in an initial public offering on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp served as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.
What is Jaguar Health's stock symbol?: Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."
Who are Jaguar Health's major shareholders?: Jaguar Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends.
How do I buy shares of Jaguar Health?: Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Jaguar Health's stock price today?: One share of JAGX stock can currently be purchased for approximately $4.24.
How much money does Jaguar Health make?: Jaguar Health (NASDAQ:JAGX) has a market capitalization of $8.18 million and generates $4.34 million in revenue each year. The biotechnology company earns $-52,600,000.00 in net income (profit) each year or ($71.4286) on an earnings per share basis.
How can I contact Jaguar Health?: Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The official website for the company is www.jaguaranimalhealth.com. The biotechnology company can be reached via phone at (415) 371-8300.

This page (NASDAQ:JAGX) was last updated on 2/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial